HRAS and hepatocellular carcinoma: We confirmed through western blot that knockdown of LL22NC03-N14H11.1 decreased H-RAS (G12V) level and increased LZTR1 level, and such results could be reversed by the knockdown of LZTR1 in HCC cells (Fig. 4f).